Diagnosis and classification of myelodysplastic syndromes.
Hasserjian RP, Germing U, Malcovati L.
Blood. 2023 Dec 28;142(26):2247-2257. doi: 10.1182/blood.2023020078.
Hypocellular Philadelphia chromosome-positive mixed-phenotype acute leukemia successfully treated with dasatinib: A case report.
Lee S, Fujita K, Wakayama H, Kito Y, Hara T, Tsurumi H.
Mol Clin Oncol. 2022 Feb;16(2):33. doi: 10.3892/mco.2021.2466. Epub 2021 Dec 14.
Hypocellular acute leukemia.
Howe RB, Bloomfield CD, McKenna RW.
Am J Med. 1982 Mar;72(3):391-5. doi: 10.1016/0002-9343(82)90494-6.
How I treat myelodysplastic syndromes of childhood.
Locatelli F, Strahm B.
Blood. 2018 Mar 29;131(13):1406-1414. doi: 10.1182/blood-2017-09-765214. Epub 2018 Feb 8.
New Approaches to Myelodysplastic Syndrome Treatment.
Bazinet A, Bravo GM.
Curr Treat Options Oncol. 2022 May;23(5):668-687. doi: 10.1007/s11864-022-00965-1. Epub 2022 Mar 23.
MDS overlap disorders and diagnostic boundaries.
Tanaka TN, Bejar R.
Blood. 2019 Mar 7;133(10):1086-1095. doi: 10.1182/blood-2018-10-844670. Epub 2019 Jan 22.
The spectrum of GATA2 deficiency syndrome.
Calvo KR, Hickstein DD.
Blood. 2023 Mar 30;141(13):1524-1532. doi: 10.1182/blood.2022017764.
[Hypocellular acute leukemia].
Sawada A, Kawa K.
Ryoikibetsu Shokogun Shirizu. 1998;(22 Pt 3):145-8.
Clinical Characteristics and Treatment Outcome of Hypocellular Acute Myeloid Leukemia Based on WHO Classification.
Čolović N, Denčić-Fekete M, Peruničić M, Jurišić V.
Indian J Hematol Blood Transfus. 2020 Jan;36(1):59-63. doi: 10.1007/s12288-019-01161-2. Epub 2019 Jul 19.
Clinical features and outcomes of hypocellular acute myeloid leukemia in adults: A Korean AML registry data.
Song IC, Jo DY, Kim HJ, Min YH, Hong DS, Lee WS, Shin HJ, Lee JH, Park J, Kim HJ.
Medicine (Baltimore). 2021 Jan 8;100(1):e24185. doi: 10.1097/MD.0000000000024185.
